BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29866190)

  • 21. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
    Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
    Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway.
    Lin JZ; Lin N; Zhao WJ
    J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
    Geng S; Tu S; Fu W; Wang J; Bai Z
    Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
    Cheng Z; Luo C; Guo Z
    J Cell Biochem; 2020 Mar; 121(3):2170-2183. PubMed ID: 31680298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
    Lou J; Hao Y; Lin K; Lyu Y; Chen M; Wang H; Zou D; Jiang X; Wang R; Jin D; Lam EW; Shao S; Liu Q; Yan J; Wang X; Chen P; Zhang B; Jin B
    Mol Cancer; 2020 Sep; 19(1):138. PubMed ID: 32894144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells.
    Bruntz RC; Taylor HE; Lindsley CW; Brown HA
    J Biol Chem; 2014 Jan; 289(2):600-16. PubMed ID: 24257753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS.
    Chen L; Zhang J; Chen Q; Ge W; Meng L; Huang X; Shen P; Yuan H; Shi G; Miao Y; Jiang K
    Int J Cancer; 2020 Jul; 147(1):175-188. PubMed ID: 31837005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
    Cai J; Zhang J; Wu P; Yang W; Ye Q; Chen Q; Jiang C
    J Neurooncol; 2018 Nov; 140(2):225-236. PubMed ID: 30043319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA H19 promotes glioblastoma multiforme development by activating autophagy by sponging miR-491-5p.
    Wang G; Lin X; Han H; Zhang H; Li X; Feng M; Jiang C
    Bioengineered; 2022 May; 13(5):11440-11455. PubMed ID: 35506168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway.
    Zhou W; Wang J; Qi Q; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Bjerkvig R; Li X; Wang J
    Cancer Med; 2018 Sep; 7(9):4729-4743. PubMed ID: 30079478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer.
    Du Y; Chen Y; Wu T; Fan X; Lin W; Jiang Z
    BMC Cancer; 2022 Jun; 22(1):689. PubMed ID: 35733138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
    Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
    J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A; Crane CA; Weng C; Feletti A; Parsa AT; Pieper RO
    Cancer Res; 2009 Oct; 69(20):7911-6. PubMed ID: 19808964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.